AzTrials
AzTrials

Lumbar RadiculopathyNCT07799142

Femoral Stretch Test in L2-L4 Lumbar Radiculopathy

An observational study of Lumbar Radiculopathy, run by Marmara University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective observational study aims to evaluate the sensitivity of the femoral stretch test in patients with unilateral, single-root L2, L3, or L4 nerve root compression and to determine whether test positivity differs according to the affected nerve root. Read more about this study

Who is it for?
Ages 18 months and older
Conditions the study is for
Lumbar Radiculopathy
Type of treatment
Injection or infusion
How many people
120 participants
Where
1 siteTurkey (Türkiye)
Study dates
7 Sep 2026to Apr 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 months and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Adult patients with lumbar radicular pain who are evaluated at a tertiary pain medicine clinic and are scheduled to undergo clinically indicated single-level, unilateral transforaminal epidural steroid injection targeting the L2, L3, or L4 nerve root will be prospectively enrolled.

Who may be able to join

  • Patients with a diagnosis of lumbar radicular pain based on medical history, physical examination, and imaging findings.
  • Patients with unilateral L2, L3, or L4 nerve root involvement who are scheduled to undergo single-level, unilateral transforaminal epidural steroid injection targeting the corresponding nerve root.

Who cannot join

  • Presence of diabetes mellitus or other medical conditions that may cause polyneuropathy.
  • Presence of active radicular pain originating from lumbosacral nerve roots other than L2, L3, or L4.
  • Unavailability of relevant radiological imaging.
  • Cognitive impairment that may interfere with clinical assessment.
  • Pregnancy.
  • Presence of local or systemic infection.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Nurbanu Hindioglu Dogan, MD contact

+902166254545

nurbanuhindioglu@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Marmara University Pendik Training and Research Hospital

    Istanbul, Pendik, 34899

    Nurbanu Hindioglu Dogan, MD, +902166254545, nurbanuhindioglu@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Root-Level Diagnostic Sensitivity of the Femoral Stretch Test in Patients With L2, L3, or L4 Nerve Root Compression: A Prospective Observational Study

This prospective observational study aims to evaluate the sensitivity of the femoral stretch test in patients with unilateral, single-root L2, L3, or L4 nerve root compression and to determine whether test positivity differs according to the affected nerve root.

Patients with unilateral radicular symptoms and magnetic resonance imaging-confirmed single-root compression involving the L2, L3, or L4 nerve root who are scheduled to undergo transforaminal epidural steroid injection as part of routine clinical care will be included. The decision to perform transforaminal epidural steroid injection will be made independently of participation in the study.

Before the procedure, the femoral stretch test, pain intensity, neuropathic pain characteristics, dermatomal concordance of symptoms, and relevant magnetic resonance imaging findings will be recorded. The femoral stretch test and pain intensity will be reassessed 1 hour after the procedure. The study will primarily evaluate the sensitivity of the femoral stretch test for L2, L3, and L4 nerve root involvement and will also assess changes in test findings following transforaminal epidural steroid injection.

Keywords
transforaminal epidural injection, femoral strecth test
Medical subject headings
Radiculopathy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07799142
Study groupRoleWhat they receive
L2 Nerve Root Compression CohortPatients with unilateral, magnetic resonance imaging-confirmed single-root L2 nerve root compression and clinically concordant radicular symptoms who are scheduled to undergo transforaminal epidural steroid injection as part of routine clinical care. Femoral stretch test findings and pain intensity will be recorded before and after the procedure.
L3 Nerve Root Compression CohortPatients with unilateral, magnetic resonance imaging-confirmed single-root L3 nerve root compression and clinically concordant radicular symptoms who are scheduled to undergo transforaminal epidural steroid injection as part of routine clinical care. Femoral stretch test findings and pain intensity will be recorded before and after the procedure.
L4 Nerve Root Compression CohortPatients with unilateral, magnetic resonance imaging-confirmed single-root L4 nerve root compression and clinically concordant radicular symptoms who are scheduled to undergo transforaminal epidural steroid injection as part of routine clinical care. Femoral stretch test findings and pain intensity will be recorded before and after the procedure.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Root-Level Sensitivity of the Femoral Stretch Test for L2, L3, and L4 Nerve Root Compression

    The sensitivity of the femoral stretch test will be calculated separately in patients with unilateral, Magnetic Resonance Imaging-confirmed single-root L2, L3, and L4 nerve root compression. Root-level sensitivities will be compared to determine whether the diagnostic sensitivity of the test differs according to the affected nerve root.

    Measured: Baseline

Secondary outcomes (4)
  1. Change in Femoral Stretch Test Positivity Following Transforaminal Epidural Steroid Injection

    Femoral stretch test results will be recorded as positive or negative immediately before and after transforaminal epidural steroid injection. The proportion of patients with a change from a positive to a negative test following the procedure will be evaluated overall and according to the affected nerve root (L2, L3, and L4).

    Measured: Baseline and 1 hour post-procedure

  2. Change in Pain Intensity Following Transforaminal Epidural Steroid Injection

    Pain intensity will be assessed using the Numeric Rating Scale, ranging from 0 (no pain) to 10 (worst imaginable pain), immediately before and after transforaminal epidural steroid injection. The change in Numeric Rating Scale score following the procedure will be evaluated.

    Measured: Baseline and 1 hour post-procedure

  3. Association Between Femoral Stretch Test Positivity and Magnetic Resonance Imaging Nerve Root Compression Severity

    The association between pre-procedural femoral stretch test positivity and the severity of nerve root compression on lumbar magnetic resonance imaging will be evaluated in patients with unilateral, single-root L2, L3, or L4 nerve root compression.

    Measured: Baseline

  4. Association Between Femoral Stretch Test Positivity and Neuropathic Pain Characteristics

    Neuropathic pain characteristics will be assessed using the 10-item DN4 neuropathic pain questionnaire, a validated screening tool for neuropathic pain. The total score ranges from 0 to 10, with higher scores indicating a greater likelihood of neuropathic pain. The association between the pre-procedural DN4 score and femoral stretch test positivity will be evaluated in patients with unilateral, single-root L2, L3, or L4 nerve root compression.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2026
  2. Study start7 Sep 2026
  3. Primary completionMar 2027 (estimated)
  4. Study completionApr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07799142
Sponsor's protocol ID
09.2025.408
Status last verified
Sep 2026
First submitted
26 Aug 2026
Last updated
11 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data are not planned to be shared publicly due to participant confidentiality and data protection considerations.

Questions about this trial

What is this clinical trial studying?

An observational study of Lumbar Radiculopathy, run by Marmara University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nurbanu Hindioglu Dogan, MD (+902166254545, nurbanuhindioglu@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Root-Level Sensitivity of the Femoral Stretch Test for L2, L3, and L4 Nerve Root Compression (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in